Press Releases April 28, 2026 10:00 PM

Xunlei Filed Its Annual Report on Form 20-F for Fiscal Year 2025

Xunlei Limited files annual Form 20-F report for fiscal year 2025 with the SEC

By Nina Shah
Share
Twitter Reddit Facebook LinkedIn
XNET

Xunlei Limited, a Chinese technology company specializing in distributed cloud services, announced the filing of its annual report on Form 20-F for the fiscal year ended December 31, 2025. The report is now accessible on both the SEC and Xunlei's investor relations websites.

Xunlei Filed Its Annual Report on Form 20-F for Fiscal Year 2025
XNET
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Xunlei filed its annual report on Form 20-F with the SEC for fiscal year 2025.
  • The company offers distributed cloud services and digital entertainment products in China.
  • The filing ensures compliance and transparency for investors in the U.S. market.

SHENZHEN, China, April 29, 2026 (GLOBE NEWSWIRE) -- Xunlei Limited (“Xunlei” or the “Company”) (NASDAQ: XNET), a leading technology company providing distributed cloud services in China, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2025 with the Securities and Exchange Commission (the “SEC”) on April 28, 2026. The annual report can be accessed on the Company’s investor relations website at http://ir.xunlei.com or the SEC’s website at www.sec.gov.

About Xunlei

Founded in 2003, Xunlei Limited (NASDAQ: XNET) is a leading technology company providing distributed cloud services in China. Xunlei provides a wide range of products and services across cloud acceleration and digital entertainment to deliver an efficient, smart and safe internet experience.

Contact:
Investor Relations
Xunlei Limited
Email: [email protected]
Tel: +86 755 6111 1571
Website: http://ir.xunlei.com


Risks

  • The company operates primarily in China, and thus is subject to regulatory and geopolitical risks impacting cross-border tech companies.
  • Market competition in cloud services and digital entertainment sectors could affect future growth.
  • Macroeconomic conditions in China may impact the business performance and investor sentiment.

More from Press Releases

Agios Showcases RISE UP Phase 3 Results at EHA 2026 Plenary Session Reinforcing Strong Anti-Hemolytic Profile of Mitapivat in Sickle Cell Disease Jun 13, 2026 Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026 Jun 13, 2026 Intellia Therapeutics Reports Additional Positive Phase 3 Results for Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema Jun 13, 2026 Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules Jun 12, 2026 Belite Bio Completes Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Tinlarebant for the Treatment of Stargardt Disease Type 1 Jun 12, 2026